A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
Clinical trial NCT06431594 · RECRUITING
Trial details
- NCT number
- NCT06431594
- Sponsor
- GlaxoSmithKline
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-02
- Primary completion
- 2027-09-22
- Enrollment
- 675
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.